|
|
Scancell Holdings Plc
LSE •
Healthcare •
Biotechnology •
Quote as of 10/28/2026 16:10
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization123.46 mln
Float118 mln
Earnings Date10/23/2026
1-Year Forecast
190.00
Transformational upside
Relative Strength
13
/ 100
Significantly lagging
Key Fundamentals
EPS-17.00
ROE129
ROIC-60.39
ROA-110
Interest Cover-8.89
EBITDA, mln-17.60
EV / EBITDA-6.94
EV / EBIT-6.68
Quote Details
Last
88.31
Change
0.31 (0.35%)
Open
90.00
Volume
78,685
Turnover
6,948,672
Average Volume
111,490
Financial Strength
Piotroski F-Score
2
/ 9
1-Year Target Price190.00
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
-2.1% |
18
/ 100
 |
| 1 Month |
-7.04% |
17
/ 100
|
| 2 Months |
-15.9% |
9
/ 100
 |
| 6 Months |
-36.47% |
5
/ 100
|
| 1 Year |
-8.96% |
20
/ 100
 |
|
| |
